Back to Treasuries

Bridge Biotherapeutics Inc

#85 in public 288330.KQ public

Parataxis Korea, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide.

Bitcoin Holdings

Total Bitcoin ₿ 200 BTC
% of 21M Supply 0.001%
Current Value $12,703,876
Cost Basis $26,363,984
ROI -51.81%
% of Company 0.0%
mNAV 1431.23x
Market Cap $36,442,669,056
Enterprise Value $18,182,185,106
Latest Purchase Feb 06, 2026
Avg. cost / BTC $131,820

Bridge Biotherapeutics Inc Stock Priced in BTC

0.006551 BTC

Bridge Biotherapeutics Inc Bitcoin Holdings Over Time

₿ 200 BTC

Bitcoin Acquisitions History

Loading acquisitions…

Company financial detail

Loading company details…

Frequently Asked Questions

Common questions about Bridge Biotherapeutics Inc's Bitcoin holdings

How much Bitcoin does Bridge Biotherapeutics Inc hold?

Bridge Biotherapeutics Inc currently holds 200 BTC, which represents 0.001% of the total Bitcoin supply (21 million). This makes them the 85th largest public Bitcoin holder.

What is the current value of Bridge Biotherapeutics Inc's Bitcoin holdings?

As of today, Bridge Biotherapeutics Inc's Bitcoin holdings are worth approximately $12,703,876. This represents 0.0% of the company's total market value.

What is Bridge Biotherapeutics Inc's average cost basis for Bitcoin?

Bridge Biotherapeutics Inc's average cost basis for their Bitcoin purchases is $26,363,984 per Bitcoin. Their current return on investment (ROI) is -51.81%.

When did Bridge Biotherapeutics Inc last buy Bitcoin?

Bridge Biotherapeutics Inc's most recent Bitcoin purchase was Feb 06, 2026. View purchase details

What type of company is Bridge Biotherapeutics Inc?

Bridge Biotherapeutics Inc is a public company in the Financial Services sector and Capital Markets industry with approximately 21 employees .

What is Bridge Biotherapeutics Inc's market capitalization?

Bridge Biotherapeutics Inc has a market capitalization of approximately $36,442,669,056 and annual revenue of $9,000,000 .

What is Bridge Biotherapeutics Inc's mNAV?

Bridge Biotherapeutics Inc's mNAV (Market-to-Net Asset Value) is 1431.23x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Bridge Biotherapeutics Inc's market cap and enterprise value?

Bridge Biotherapeutics Inc has a market capitalization of $36,442,669,056 and an enterprise value of $18,182,185,106. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Other public Companies

Similar companies with Bitcoin treasury holdings

Strategy, Inc

MSTR

Holdings 840,447 BTC
Value $53,384,672,363
ROI -13.63%

Twenty One Capital, Inc.

XXI

Holdings 43,514 BTC
Value $2,763,982,301
ROI -40.73%

Metaplanet Inc.

MTPLF

Holdings 43,000 BTC
Value $2,731,333,340
ROI -36.95%

Marathon Digital Holdings Inc

MARA

Holdings 35,303 BTC
Value $2,242,424,672
ROI -17.15%

Cantor Equity Partners I, Inc.

CEPO

Holdings 30,021 BTC
Value $1,906,915,307
ROI -47.07%
Chat

Loading…

Opening chat…